1. Home
  2. CPF vs PCRX Comparison

CPF vs PCRX Comparison

Compare CPF & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Central Pacific Financial Corp New

CPF

Central Pacific Financial Corp New

HOLD

Current Price

$31.83

Market Cap

903.1M

Sector

Finance

ML Signal

HOLD

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$22.10

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPF
PCRX
Founded
1954
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
903.1M
1.0B
IPO Year
2011
2010

Fundamental Metrics

Financial Performance
Metric
CPF
PCRX
Price
$31.83
$22.10
Analyst Decision
Buy
Strong Buy
Analyst Count
2
6
Target Price
$35.50
$35.33
AVG Volume (30 Days)
150.6K
604.8K
Earning Date
04-29-2026
05-15-2026
Dividend Yield
3.44%
N/A
EPS Growth
N/A
107.44
EPS
2.01
0.16
Revenue
$38,723,000.00
$541,533,000.00
Revenue This Year
N/A
$6.21
Revenue Next Year
$4.37
$8.26
P/E Ratio
$16.77
$188.17
Revenue Growth
N/A
26.04
52 Week Low
$23.16
$18.80
52 Week High
$35.01
$27.99

Technical Indicators

Market Signals
Indicator
CPF
PCRX
Relative Strength Index (RSI) 39.32 48.26
Support Level $30.42 $20.35
Resistance Level $34.84 $27.24
Average True Range (ATR) 0.98 0.86
MACD -0.26 0.16
Stochastic Oscillator 7.76 47.75

Price Performance

Historical Comparison
CPF
PCRX

About CPF Central Pacific Financial Corp New

Central Pacific Financial Corp operates in the financial services sector in the United States. It is a full-service commercial bank offering a broad range of banking products and services, including accepting time and demand deposits and originating loans. Bank's deposits are insured by the Federal Deposit Insurance Corporation (FDIC) up to applicable limits. The bank is not a member of the Federal Reserve System. The company's loans include commercial loans, construction loans, commercial and residential mortgage loans, and consumer loans. The company derives income from interest and fees on loans, interest on investment securities, and fees received in connection with deposits and other services.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: